Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging
- 1 January 2019
- journal article
- conference paper
- Published by Elsevier in Journal of Proteomics
- Vol. 191, 114-123
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (18445)
This publication has 33 references indexed in Scilit:
- An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid CarcinomaEndocrine Pathology, 2013
- Lumican expression, localization and antitumor activity in prostate cancerExperimental Cell Research, 2013
- Lumican effects in the control of tumour progression and their links with metalloproteinases and integrinsThe FEBS Journal, 2013
- Secretory Sorting Receptors Carboxypeptidase E and Secretogranin III in Amyloid β‐Associated Neural Degeneration in Alzheimer's DiseaseBrain Pathology, 2012
- Moesin expression is a marker of basal breast carcinomasInternational Journal of Cancer, 2007
- Absence of RET Gene Point Mutations in Sporadic Thyroid C-Cell HyperplasiaThe Journal of Molecular Diagnostics, 2007
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissueMolecular Carcinogenesis, 2006
- Unraveling the Amyloid Associated with Human Medullary Thyroid CarcinomaEndocrinology, 2004
- Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.Journal of Experimental Medicine, 1976